Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 140, 2020 - Issue 4
Submit an article Journal homepage
196
Views
5
CrossRef citations to date
0
Altmetric
Otoneurology

Efficacy and safety of terbinafine hydrochloride spray and 3% boric acid alcohol ear drops in otomycosis

Shuai XuDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaView further author information
,
Jianfeng LiDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaView further author information
,
Ling DingDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaView further author information
,
Kun GaoDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaView further author information
,
Fengyang XieDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaView further author information
,
Jie HanDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaCorrespondence[email protected]
View further author information
&
Xuanchen ZhouDepartment of Otorhinolaryngology Head and Neck Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 302-306 | Received 29 Oct 2019, Accepted 14 Dec 2019, Published online: 05 Feb 2020

References

  • Musa TS, Bemu AN, Grema US, et al. Pattern of otitis externa in Kaduna Nigeria. Pan Afr Med J. 2015;21:165.
  • Pontes ZB, Silva AD, Lima Ede O, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol (Impr). 2009;75:367–370.
  • de la Paz Cota BR, Cepero Vega PP, Matus Navarrete JJ, et al. Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis. Am J Otolaryngol. 2018;39:307–312.
  • Vennewald I, Schonlebe J, Klemm E. Mycological and histological investigations in humans with middle ear infections. Mycoses. 2003;46:12–18.
  • Hoshino T, Matsumoto M. Otomycosis: subdermal growth in calcified mass. Eur Arch Otorhinolaryngol. 2006;263:875–878.
  • Agarwal P, Devi LS. Otomycosis in a rural community attending a tertiary care hospital: assessment of risk factors and identification of fungal and bacterial agents. J Clin Diagn Res. 2017;11:DC14–DC18.
  • Jackman A, Ward R, April M, et al. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005;69:857–860.
  • Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30:564–567.
  • Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol. 2001;115:879–880.
  • Ho T, Vrabec JT, Yoo D, et al. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006;135:787–791.
  • Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001;44:472–479.
  • del Palacio A, Cuetara MS, Lopez-Suso MJ, et al. Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses. 2002;45:317–328.
  • Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003;112:384–387.
  • Kaur R, Mittal N, Kakkar M, et al. Otomycosis: a clinicomycologic study. Ear Nose Throat J. 2000;79:606–609.
  • Kiakojori KB, Jamnani N, Khafri S, et al. Assessment of response to treatment in patients with otomycosis. Iran J Otorhinolaryngol. 2018;30:41–47.
  • Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72:453–459.
  • Ozcan KM, Ozcan M, Karaarslan A, et al. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003;117:39–42.
  • Khan F, Muhammad R, Khan MR, et al. Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med Coll Abbottabad. 2013;25:78–80.
  • Romsaithong S, Tomanakan K, Tangsawad W, et al. Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial. J Laryngol Otol. 2016;130:811–815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.